GGrantIndex
← Leaderboards

Lucy Ann Godley

University Of Chicago

$5,215,217
Attributed
$9,700,249
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200825
$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,700,249 · 8

By mechanism

R01$3,892,832 · 2
U01$3,181,826 · 2
U24$1,507,456 · 1
R21$826,458 · 2
P20$291,677 · 1

Top collaborators

Most similar at University Of Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Laboratories

Research focus

LaboratoriesMalignant NeoplasmsHematopoietic NeoplasmsPhenotypeProgramsPathway InteractionsMutationCellsLeukemiaInterestSamplingPredispositionGenesMediatingBaseSyndromeAffectVariantGene ExpressionFamilyDefectRunx1 GeneInnovationCharacteristics

Grant awards (28)

The role of inflammation in driving leukemogenesis in germline predisposition syndromes$497,412
U01 · FY2025 · CA · contact PI
Myeloid Malignancy Variant Curation Expert Panel$293,902
U24 · FY2025 · CA · contact PI
Transforming health at the intersection of implementation science, learning health systems, and genomics at Northwestern Medicine$666,062
U01 · FY2024 · HG
The role of inflammation in driving leukemogenesis in germline predisposition syndromes$622,915
U01 · FY2024 · CA · contact PI
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche$504,283
R01 · FY2024 · HL
Myeloid Malignancy Variant Curation Expert Panel$322,766
U24 · FY2024 · CA · contact PI
The role of inflammation in driving leukemogenesis in germline predisposition syndromes$687,587
U01 · FY2023 · CA · contact PI
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche$516,884
R01 · FY2023 · HL
Myeloid Malignancy Variant Curation$266,334
U24 · FY2023 · CA · contact PI
Myeloid Malignancy Variant Curation Expert Panel$23,343
U24 · FY2023 · CA · contact PI
The role of inflammation in driving leukemogenesis in germline predisposition syndromes$707,850
U01 · FY2022 · CA · contact PI
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche$519,194
R01 · FY2022 · HL
Myeloid Malignancy Variant Curation Expert Panel$297,301
U24 · FY2022 · CA · contact PI
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche$532,884
R01 · FY2021 · HL
Myeloid Malignancy Variant Curation Expert Panel$303,810
U24 · FY2021 · CA · contact PI
Developmental Research Program$98,208
P20 · FY2020 · CA · contact PI
Developmental Research Program$95,261
P20 · FY2019 · CA · contact PI
Developmental Research Program$98,208
P20 · FY2018 · CA · contact PI
The Role of DNMT3B in the DNA Methylation of Cancer Cells$350,219
R01 · FY2012 · CA · contact PI
Epigenetic and Genetic Dissection of Drug Response$211,858
R21 · FY2012 · HG
The Role of DNMT3B in the DNA Methylation of Cancer Cells$441,011
R01 · FY2011 · CA · contact PI
Epigenetic and Genetic Dissection of Drug Response$250,610
R21 · FY2011 · HG
The Role of DNMT3B in the DNA Methylation of Cancer Cells$314,250
R01 · FY2010 · CA · contact PI
A chemical crosslinking strategy to determine DNA methylating protein complexes$164,835
R21 · FY2010 · CA · contact PI
The Role of DNMT3B in the DNA Methylation of Cancer Cells$93,600
R01 · FY2010 · CA · contact PI
The Role of DNMT3B in the DNA Methylation of Cancer Cells$314,250
R01 · FY2009 · CA · contact PI
A chemical crosslinking strategy to determine DNA methylating protein complexes$199,155
R21 · FY2009 · CA · contact PI
The Role of DNMT3B in the DNA Methylation of Cancer Cells$306,257
R01 · FY2008 · CA · contact PI